Patents by Inventor Stefanie Vogel

Stefanie Vogel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADMINISTRATION OF ERITORAN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT ORTHOMYXOVIRUS INFECTIONS
    Publication number: 20160022717
    Abstract: The present invention is directed to methods for treating orthomyxovirus infections comprising administering to a subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 31, 2015
    Publication date: January 28, 2016
    Applicant: UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Stefanie VOGEL, Kari Ann Shirey
  • Administration of eritoran or pharmaceutically acceptable salts thereof to treat orthomyxovirus infections
    Patent number: 9132141
    Abstract: The present invention is directed to methods for treating orthomyxovirus infections comprising administering to a subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 4, 2013
    Date of Patent: September 15, 2015
    Assignee: UNIVERSITY OF MARYLAND, BALTIMORE
    Inventors: Stefanie Vogel, Kari Ann Shirey
  • ADMINISTRATION OF ERITORAN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF TO TREAT ORTHOMYXOVIRUS INFECTIONS
    Publication number: 20130261076
    Abstract: The present invention is directed to methods for treating orthomyxovirus infections comprising administering to a subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 4, 2013
    Publication date: October 3, 2013
    Applicant: University of Maryland
    Inventors: Stefanie Vogel, Kari Ann Shirey
  • CXCR3 is a gliadin receptor
    Publication number: 20070048801
    Abstract: Gliadin is identified as a physiological receptor for CXCR3. Assays for determining modulators of CXCR3 signaling are provided. Fragments of gliadin which function as inhibitors of CXCR3 signaling can be determined. Methods for treating diseases relating to gluten and/or autoimmunity by targeting CXCR3 are provided. Such diseases include celiac disease, gluten sensitivity, gluten allergy, rheumatoid arthritis, multiple sclerosis, immune-mediated or type 1 diabetes mellitus, inflammatory bowel diseases, systemic lupus erythematosus, psoriasis, scleroderma, and autoimmune thyroid diseases.
    Type: Application
    Filed: February 16, 2006
    Publication date: March 1, 2007
    Applicant: University of Maryland, Baltimore
    Inventors: Alessio Fasano, Ruiliang Lu, Stefanie Vogel, Julie Brownley, Karen Lammers
  • Methods of Treating A Bacterial Infection using F. Tularensis Lipopolysaccharide
    Publication number: 20070042004
    Abstract: The present invention relates to the ability of Francisella tularensis LVS lipopolysaccharide (LPS) to confer protection in a subject against a subsequent bacterial infection. Accordingly, the invention provides methods of treating and preventing bacterial infection in a subject by administering F. tularensis LPS to the subject. The invention also relates to methods of modulating the immune response in a subject comprising administering F. tularensis LPS to the subject.
    Type: Application
    Filed: June 6, 2006
    Publication date: February 22, 2007
    Inventors: Stefanie Vogel, Leah Cole
  • Agonist polypeptide of receptor for ZOT and zonulin
    Publication number: 20060276403
    Abstract: Agonist polypeptide of a receptor protein has been identified. The agonist can be used to facilitate drug and antigen absorption. Suitable routes of administration include oral, nasal, transdermal, and intravenous. Pharmaceutical formulations may comprise a therapeutic agent or an immunogenic agent in combination with the agonist polypeptide.
    Type: Application
    Filed: August 11, 2006
    Publication date: December 7, 2006
    Applicant: University of Maryland - Baltimore
    Inventors: Alessio Fasano, Stefanie Vogel
  • Agonist polypeptide of receptor for Zot and Zonulin
    Publication number: 20050059593
    Abstract: Agonist polypeptide of a receptor protein has been identified. The agonist can be used to facilitate drug and antigen absorption. Suitable routes of administration include oral, nasal, transdermal, and intravenous. Pharmaceutical formulations may comprise a therapeutic agent or an immunogenic agent in combination with the agonist polypeptide.
    Type: Application
    Filed: July 15, 2004
    Publication date: March 17, 2005
    Applicant: University of Maryland, Baltimore
    Inventors: Alessio Fasano, Stefanie Vogel